A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Peking Union Medical College Hospital, Beijing

Peking University International Hospital, Beijing

The First Hospital of China Medical University, Shenyang

The First Hospital of Jilin University, Changchun

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

Shanghai Sixth People's Hospital, Shanghai

Jiangsu Province Hospital, Suzhou

Qilu Hospital of Shandong University, Jinan

Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical, Tianjin

Tianjin Medical University General Hospital, Tianjin

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

The First Affiliated Hospital of Xiamen University, Xiamen

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

Henan Cancer Hospital, Zhengzhou

Guangdong Provincial People's Hospital, Guangzhou

Zhujiang Hospital Of Southern Medical University, Guangzhou

Nanfang Hospital, Guangzhou

Shenzhen Second People's Hospital, Shenzhen

The Affiliated Hospital of Guizhou Medical University, Guiyang

The second Affiliated Hospital of Kunming Medical University, Kunming

The Second Affiliated Hospital of Xi'an Jiaotong University（Xibei Hospital）, Xi’an

Beijing Boren Hospital, Beijing

Sun Yat-sen University Cancer Center, Guangzhou

The Second Hospital of HeBei Medical University, Shijiazhuang